Featured Articles

1. Thinking Small: A Counterintuitive Strategy For Biopharma Startups 2/2/2026

   There is more than one way to blockbuster product sales, and sometimes smaller might be better, writes Bennett Smith.

2. A Year Of Separation: Which Advanced Modalities Are Built For Commercial Scale In 2026? 1/30/2026

   In 2026, advanced therapies diverge: winners pair proven biology with scalable manufacturing, delivery, and workflow fit, while others advance more slowly under operational and economic limits.

3. Why 'Be Your Authentic Self' Is Actually Bad Advice 1/23/2026

   Raw authenticity can be disruptive in life sciences workplaces, but learning corporate fluency and stylistic pivots can help leaders become strategically authentic, writes Hope Mueller.

4. A Serial Biotech Entrepreneur's Recipe For Success 1/21/2026

   Pushing boundaries, staying grounded, and having fun along the way are the key ingredients for success in biotech, writes Nuvation Bio Founder, President, and CEO David Hung, M.D.

5. From Lab To Launch: Navigating The Transition To Commercial Readiness 1/13/2026

   Many clinical-stage companies start thinking about commercialization too late. FTI Consulting experts team up to provide guidance on getting started early.

6. Visibility Without Discoverability: A Life Sciences Marketing Challenge 1/9/2026

   Life sciences organizations are highly visible and active across established media channels, but discoverability represents an area of untapped potential, writes Daan Inghelram.

7. Building Biotech's Future: The Strategic Imperative Of AI Integration 1/6/2026

   Biotech companies that will lead the next decade won't just have better science, they'll have superior operating models, writes Samina Bari.

8. FDA Further Expands And Clarifies Expanded Access FAQs 12/29/2025

   Healthcare attorney Dianne J. Bourque breaks down the FDA's October 2025 update to its Expanded Access FAQs.

9. Your Microbiome Might Be Trying To Tell You Something 12/22/2025

   Burnout is not an individual failure: it’s a systems imbalance, biologically and organizationally, write Tony Martignetti and Adela Bonoiu, Ph.D. 

10. 2025's Top 5 Drug Discovery Highlights And How To Stay Ahead In 2026 12/15/2025

    Drug Discovery Online's 2025 Top 5 most consequential shifts affecting this rapidly evolving field, including NAMs, AI, Individualized Therapies, Innovating China, and Early-stage Funding Volatility.